SIMM
MIRO

Stillwater Investment Management (Minnesota)’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Stillwater Investment Management (Minnesota)’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-90,146
Closed -$357K – 89
2022
Q1 		$357K Buy
+90,146
New +$336K 0.09% 72

Other funds holding MIRO

GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFP
Sweet Financial Partners Fairmont, Minnesota $462M AUM 26.73% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Stillwater Investment Management (Minnesota)'s MIRO Position: Q2 2022 in Review

Stillwater Investment Management (Minnesota) sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q2 2022, closing a stake of 90,146 shares — an estimated $357K sold.

Stillwater Investment Management (Minnesota) first reported a position in MIRO in Q1 2022 and held it in 1 quarter. The position peaked at $357K in Q1 2022. 22 funds tracked by Wall St. Rank hold MIRO as of Q2 2022.

  • Stillwater Investment Management (Minnesota) reported no remaining Miromatrix Medical Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Stillwater Investment Management (Minnesota) sold 90,146 Miromatrix Medical Inc. Common Stock shares in Q2 2022, an estimated $357K.
  • Stillwater Investment Management (Minnesota) first reported a position in Miromatrix Medical Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Stillwater Investment Management (Minnesota)'s Miromatrix Medical Inc. Common Stock position peaked at $357K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q2 2022.

Based on Stillwater Investment Management (Minnesota)'s 13F filing for Q2 2022, filed 5 Jul 2022.